Conclusions
hyperlactatemia, coagulopathy
COAGULOPATHY
The presence of coagulopathy and hyperlactatemia at ICU admission may be useful to select patients for PMX-HA; even those with high endotoxin activity. Our findings could help tailor the use of PMX-HA and serve to guide future trials.